Algal DHA and ARA Market Size, Share, Growth, and Industry Analysis, By Type (DHA Oil,DHA Powder,ARA Oil,ARA Powder), By Application (Infant Formula,Food and Beverage,Nutritional Supplement,Others), Regional Insights and Forecast to 2035

Algal DHA and ARA Market Overview

The global Algal DHA and ARA Market is forecast to expand from USD 719.44 million in 2026 to USD 815.27 million in 2027, and is expected to reach USD 2200 million by 2035, growing at a CAGR of 13.32% over the forecast period.

The Algal DHA and ARA Market is expanding rapidly, with global production of algal oils surpassing 45,000 metric tons in 2024. Demand from infant formula accounts for nearly 40% of total consumption, while nutritional supplements and food applications collectively represent another 45%. More than 60% of global algal DHA output comes from microalgae fermentation plants in Asia-Pacific, while Europe accounts for 25% of specialized refining capacity. Industrial-scale production facilities are concentrated in China, India, and the United States, each with more than 10,000 metric tons combined output annually. Rising functional food launches have increased algal DHA and ARA use by 18% over the past three years.

The United States is one of the largest importers and consumers of algal DHA and ARA, with domestic demand exceeding 12,000 metric tons in 2023. Infant formula applications account for 45% of U.S. DHA and ARA consumption, while dietary supplements represent around 35%. The U.S. imports nearly 50% of its algal oil requirements from Asia-Pacific suppliers, mainly China and India, while local production capacity surpasses 6,000 metric tons annually. Retail supplement launches containing algal DHA increased by 20% in 2023, reflecting strong growth in the health and wellness segment. The U.S. market continues to drive B2B demand across infant nutrition, food, and pharma-grade formulations.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 40–45% of demand is concentrated in infant formula, with DHA accounting for 70% of inclusion and ARA 30%.
• Major Market Restraint: 28–32% of producers report high fermentation costs, and 25% of buyers face price sensitivity in low-income markets.
• Emerging Trends: 20–25% growth in vegan-certified algal DHA products, and 22% increase in powder formulations launched since 2021.
• Regional Leadership: Asia-Pacific contributes 42% of output, North America 30%, Europe 20%, and Middle East & Africa 8%.
• Competitive Landscape: Top five companies hold 55–60% share, with DSM and ADM alone controlling over 30%.
• Market Segmentation: DHA oil and powder represent 60% of total demand, while ARA oil and powder contribute 40%.
• Recent Development: Algal DHA supplement launches increased by 18% in 2023, and infant formula fortification expanded to 75% of global brands.

Algal DHA and ARA Market Latest Trends

Trends in the Algal DHA and ARA Market highlight rising consumer preference for plant-based omega-3 and omega-6 sources. In 2024, infant formula fortified with algal DHA and ARA accounted for nearly 75% of global formula brands, representing more than 1.2 million tons of fortified products. The demand for vegan and sustainable alternatives grew sharply, with certified algal DHA supplements rising by 22% in new launches from 2021 to 2023. Powder formulations expanded 18% during the same period, serving ready-to-mix beverages, dairy alternatives, and nutraceutical powders. Nutritional supplement usage of algal DHA surpassed 18,000 metric tons globally in 2023, accounting for 35% of market share. Regional trade analysis shows North America and Europe together import over 20,000 metric tons annually, while Asia-Pacific leads in fermentation-based production capacity with more than 60% of global output. Consumer demand in the U.S. alone increased by 15% in 2023 compared to 2021, reflecting strong growth in B2B and B2C opportunities.

Algal DHA and ARA Market Dynamics

DRIVER

"Rising demand for infant nutrition and plant-based supplements is the primary growth driver."

Global infant formula consumption exceeded 2.5 million tons in 2023, with 75% of products fortified with DHA and ARA. Algal sources now supply over 65% of DHA used in global infant formula due to their purity and sustainability compared with fish oil. Dietary supplements accounted for more than 18,000 metric tons of algal DHA use in 2023, reflecting increased adoption by vegan and vegetarian consumers. Over 1,200 new algal DHA-containing products were launched globally between 2021 and 2023, boosting demand across nutraceuticals and functional food industries.

RESTRAINT

"High fermentation and downstream processing costs limit adoption."

Algal fermentation requires bioreactors operating at scale, and more than 28% of producers report high input costs for substrates and energy. Downstream purification consumes 25–30% of production expenses, raising final costs compared to fish oil DHA. Price-sensitive markets, particularly in Africa and South Asia, restrict widespread use, with only 45% of low-cost infant formula brands fortified with DHA and ARA. In addition, 20% of small-scale supplement brands avoid algal sources due to cost concerns.

OPPORTUNITY

"Expansion in vegan-certified products and powder formulations presents strong opportunities."

The vegan population surpassed 80 million globally in 2023, creating strong demand for plant-based DHA and ARA. Vegan-certified algal oils now represent 25% of the supplement market, a share that doubled in three years. Powder formulations captured 22% of total DHA and ARA sales by 2023, expanding into ready-to-drink beverages, dairy alternatives, and functional powders. Over 15,000 tons of algal DHA powder were consumed in 2023, highlighting opportunities for manufacturers investing in spray-drying and encapsulation technologies.

CHALLENGE

"Price volatility and scalability pose major challenges."

Fermentation yield varies between 15–20 grams of DHA per liter of culture medium, and batch-to-batch fluctuations cause 10–12% output inconsistencies. Price volatility has been recorded at 15–20% annually in certain markets due to raw material shortages and energy costs. More than 30% of small producers face scalability issues, limiting their ability to supply large B2B contracts. Supply chain disruptions in 2021–2023 affected 25% of shipments, with delivery delays of up to 30 days reported by buyers in Europe and North America.

Algal DHA and ARA Market Segmentation

Segmentation in the Algal DHA and ARA Market is defined by type (DHA oil, DHA powder, ARA oil, ARA powder) and application (Infant Formula, Food and Beverage, Nutritional Supplement, Others). DHA accounts for nearly 60% of demand, while ARA covers 40%.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

DHA Oil: DHA oil represents 40% of total demand, with over 18,000 metric tons consumed in 2023. Used mainly in infant formula and supplements, it provides high bioavailability and purity, with 70% of formula brands using algal DHA oil.

The DHA oil segment is valued at USD 253.94 million in 2025, holding 40% share of the market, and projected to reach USD 789.33 million by 2034 at a CAGR of 13.45%.

Top 5 Major Dominant Countries in the DHA Oil Segment

• United States: Market size USD 88.88 million in 2025 with 35% share, expected to reach USD 275.26 million by 2034 at a CAGR of 13.5%, supported by infant formula and supplement adoption.
• China: Market size USD 63.48 million in 2025 with 25% share, projected to reach USD 202.26 million by 2034 at 13.6% CAGR, driven by food fortification and infant nutrition expansion.
• Germany: Market size USD 27.93 million in 2025 with 11% share, reaching USD 87.84 million by 2034 at a CAGR of 13.7%, backed by supplement demand and clinical nutrition.
• India: Market size USD 25.39 million in 2025 with 10% share, projected USD 79.14 million by 2034 at 13.9% CAGR, fueled by plant-based supplement manufacturing.
• Japan: Market size USD 22.85 million in 2025 with 9% share, expected to reach USD 70.65 million by 2034 at 13.4% CAGR, led by DHA-rich fortified dairy products.

DHA Powder: DHA powder holds 20% of the market, with more than 9,000 metric tons consumed in 2023. Powder forms are used in ready-to-mix drinks, dairy alternatives, and infant cereal. Spray-dried encapsulated powders have 70–90% stability efficiency.

The DHA powder segment is valued at USD 126.97 million in 2025, holding 20% share of the market, and projected to reach USD 391.24 million by 2034 at a CAGR of 13.42%.

Top 5 Major Dominant Countries in the DHA Powder Segment

• United States: Market size USD 38.09 million in 2025 with 30% share, projected USD 117.37 million by 2034 at a CAGR of 13.4%, driven by powdered infant formula and supplements.
• China: Market size USD 31.74 million in 2025 with 25% share, reaching USD 97.81 million by 2034 at 13.6% CAGR, supported by infant milk powder enrichment.
• France: Market size USD 12.70 million in 2025 with 10% share, projected USD 39.12 million by 2034 at a CAGR of 13.5%, boosted by functional food launches.
• Japan: Market size USD 12.70 million in 2025 with 10% share, reaching USD 39.12 million by 2034 at a CAGR of 13.6%, driven by dietary supplements.
• India: Market size USD 11.43 million in 2025 with 9% share, projected USD 35.21 million by 2034 at 13.7% CAGR, led by nutraceutical powder production.

ARA Oil: ARA oil accounts for 30% of market volume, with 12,000 metric tons consumed in 2023. Infant formula represents 80% of its usage, with high demand in Asia-Pacific and Europe. Over 60% of infant formula brands use ARA oil.

The ARA oil segment is valued at USD 190.46 million in 2025, representing 30% of the market, and forecasted to reach USD 586.86 million by 2034 at a CAGR of 13.28%.

Top 5 Major Dominant Countries in the ARA Oil Segment

• China: Market size USD 57.14 million in 2025 with 30% share, projected USD 176.05 million by 2034 at 13.4% CAGR, strongly linked to infant formula production.
• United States: Market size USD 47.61 million in 2025 with 25% share, expected USD 146.71 million by 2034 at 13.2% CAGR, with wide adoption in clinical nutrition.
• Germany: Market size USD 19.05 million in 2025 with 10% share, reaching USD 58.68 million by 2034 at 13.3% CAGR, supported by fortified food products.
• India: Market size USD 17.14 million in 2025 with 9% share, projected USD 52.82 million by 2034 at 13.5% CAGR, driven by supplement growth.
• Japan: Market size USD 15.24 million in 2025 with 8% share, expected USD 46.95 million by 2034 at 13.4% CAGR, supported by advanced food fortification.

ARA Powder: ARA powder is 10% of demand, with 4,500 metric tons consumed globally in 2023. Applications include fortified food powders and nutraceutical blends. Powder form supports stable incorporation in bakery and dairy substitutes.

The ARA powder segment is valued at USD 63.50 million in 2025, representing 10% share, and projected to reach USD 188.77 million by 2034 at a CAGR of 13.24%.

Top 5 Major Dominant Countries in the ARA Powder Segment

• United States: Market size USD 19.05 million in 2025 with 30% share, projected USD 56.63 million by 2034 at a CAGR of 13.2%, supported by infant nutrition powders.
• China: Market size USD 15.87 million in 2025 with 25% share, expected USD 47.19 million by 2034 at 13.3% CAGR, used in fortified milk powders.
• United Kingdom: Market size USD 6.35 million in 2025 with 10% share, projected USD 18.88 million by 2034 at 13.4% CAGR, with demand from nutraceutical producers.
• France: Market size USD 5.71 million in 2025 with 9% share, reaching USD 16.99 million by 2034 at 13.3% CAGR, tied to dietary supplement innovation.
• India: Market size USD 5.08 million in 2025 with 8% share, projected USD 15.10 million by 2034 at 13.5% CAGR, supporting powder-based supplement exports.

BY APPLICATION

Infant Formula: Infant formula dominates demand with 40% share, using over 20,000 metric tons of DHA and ARA in 2023. More than 75% of global infant formula brands now include algal-sourced fatty acids.

The infant formula application is valued at USD 253.94 million in 2025 with 40% share and projected to reach USD 782.48 million by 2034 at a CAGR of 13.3%.

Top 5 Major Dominant Countries in the Infant Formula Application

• United States: USD 76.18 million in 2025 with 30% share, projected USD 234.74 million by 2034 at 13.3% CAGR, with fortified formula representing 80% of domestic brands.
• China: USD 63.48 million in 2025 with 25% share, projected USD 195.62 million by 2034 at 13.4% CAGR, dominating with high infant population demand.
• Germany: USD 25.39 million in 2025 with 10% share, reaching USD 78.25 million by 2034 at 13.5% CAGR, led by clinical formula production.
• India: USD 22.85 million in 2025 with 9% share, projected USD 70.65 million by 2034 at 13.4% CAGR, with rising formula exports.
• Japan: USD 20.31 million in 2025 with 8% share, expected USD 62.66 million by 2034 at 13.3% CAGR, tied to high nutritional standards.

Food and Beverage: Food and beverage applications use 25% of supply, with 12,000 metric tons consumed in 2023. This segment includes dairy alternatives, bakery, and fortified beverages. New launches increased by 18% between 2021–2023.

The food and beverage application is valued at USD 158.72 million in 2025 with 25% share and projected to reach USD 489.05 million by 2034 at a CAGR of 13.32%.

Top 5 Major Dominant Countries in the Food and Beverage Application

• United States: USD 47.62 million in 2025 with 30% share, projected USD 146.71 million by 2034 at 13.3% CAGR, supported by fortified dairy and beverages.
• China: USD 39.68 million in 2025 with 25% share, reaching USD 122.26 million by 2034 at 13.4% CAGR, with fortified food demand expansion.
• France: USD 15.87 million in 2025 with 10% share, projected USD 48.91 million by 2034 at 13.2% CAGR, with bakery fortification growth.
• Germany: USD 14.28 million in 2025 with 9% share, reaching USD 44.02 million by 2034 at 13.4% CAGR, with functional food launches.
• India: USD 12.70 million in 2025 with 8% share, projected USD 39.13 million by 2034 at 13.5% CAGR, tied to health-focused food innovation.

Nutritional Supplement: Supplements account for 30% of usage, with 15,000 metric tons of DHA and ARA consumed in 2023. More than 1,200 new supplements containing algal fatty acids launched globally between 2021 and 2023.

The nutritional supplement application is valued at USD 190.46 million in 2025 with 30% share and projected to reach USD 586.86 million by 2034 at a CAGR of 13.3%.

Top 5 Major Dominant Countries in the Nutritional Supplement Application

• United States: USD 57.14 million in 2025 with 30% share, projected USD 176.06 million by 2034 at 13.2% CAGR, supported by vegan supplement launches.
• China: USD 47.62 million in 2025 with 25% share, expected USD 146.71 million by 2034 at 13.4% CAGR, with functional supplement expansion.
• Japan: USD 19.05 million in 2025 with 10% share, projected USD 58.69 million by 2034 at 13.3% CAGR, focused on dietary supplement use.
• Germany: USD 17.14 million in 2025 with 9% share, reaching USD 52.82 million by 2034 at 13.4% CAGR, driven by pharma-grade supplements.
• India: USD 15.24 million in 2025 with 8% share, projected USD 46.95 million by 2034 at 13.5% CAGR, with nutraceutical powder adoption.

Others: Other uses, including pharmaceuticals and cosmetics, account for 5% of demand with 2,500 metric tons consumed. Emerging applications include skincare formulations and prescription medical nutrition.

The others application is valued at USD 31.74 million in 2025 with 5% share and projected to reach USD 97.81 million by 2034 at a CAGR of 13.3%.

Top 5 Major Dominant Countries in the Others Application

• United States: USD 9.52 million in 2025 with 30% share, projected USD 29.34 million by 2034 at 13.2% CAGR, in pharmaceuticals and cosmetics.
• China: USD 7.94 million in 2025 with 25% share, reaching USD 24.45 million by 2034 at 13.3% CAGR, applied in cosmeceuticals.
• France: USD 3.17 million in 2025 with 10% share, projected USD 9.78 million by 2034 at 13.4% CAGR, tied to medical nutrition.
• Germany: USD 2.86 million in 2025 with 9% share, projected USD 8.81 million by 2034 at 13.3% CAGR, driven by pharma adoption.
• India: USD 2.54 million in 2025 with 8% share, reaching USD 7.83 million by 2034 at 13.5% CAGR, expanding in skincare and wellness.

Algal DHA and ARA Market Regional Outlook

Asia-Pacific dominates production with 42% share, North America accounts for 30%, Europe holds 20%, and Middle East & Africa represents 8%. Asia leads in fermentation capacity, while North America and Europe lead in consumption and imports.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America holds around 30% of the market, with demand surpassing 15,000 metric tons annually. The United States represents over 80% of this share, with infant formula accounting for 45% of use and supplements 35%. More than 500 new supplement products containing algal DHA and ARA launched in North America between 2021 and 2023. Canada and Mexico together consume about 3,000 metric tons annually, mainly for infant formula and dairy alternative products.

The North America market is valued at USD 190.46 million in 2025, holding 30% share, and projected to reach USD 586.86 million by 2034 at a CAGR of 13.3%.

North America - Major Dominant Countries in the Algal DHA and ARA Market

• United States: USD 152.37 million in 2025 with 80% share, projected USD 469.49 million by 2034 at 13.3% CAGR, leading in infant formula and supplement demand.
• Canada: USD 19.05 million in 2025 with 10% share, projected USD 58.69 million by 2034 at 13.2% CAGR, growing in fortified foods.
• Mexico: USD 9.52 million in 2025 with 5% share, projected USD 29.34 million by 2034 at 13.4% CAGR, tied to nutritional supplements.
• Cuba: USD 4.77 million in 2025 with 2.5% share, projected USD 14.70 million by 2034 at 13.3% CAGR, supporting healthcare sector growth.
• Puerto Rico: USD 4.77 million in 2025 with 2.5% share, projected USD 14.70 million by 2034 at 13.4% CAGR, focused on fortified food consumption.

Europe

Europe accounts for 20% of market share, consuming about 10,000 metric tons in 2023. Major markets include Germany, France, and the UK, which together represent 65% of European demand. Infant formula accounts for 50% of usage in Europe, with supplements making up 30%. Over 400 new product launches featuring algal DHA and ARA occurred in Europe between 2021–2023.

The Europe market is valued at USD 158.72 million in 2025 with 25% share and expected to reach USD 489.05 million by 2034 at a CAGR of 13.3%.

Europe - Major Dominant Countries in the Algal DHA and ARA Market

• Germany: USD 47.62 million in 2025 with 30% share, projected USD 146.71 million by 2034 at 13.4% CAGR, leading in supplements and infant formula.
• France: USD 31.74 million in 2025 with 20% share, projected USD 97.81 million by 2034 at 13.3% CAGR, focused on functional foods.
• United Kingdom: USD 28.57 million in 2025 with 18% share, projected USD 88.05 million by 2034 at 13.4% CAGR, in fortified dairy.
• Italy: USD 23.81 million in 2025 with 15% share, projected USD 73.35 million by 2034 at 13.3% CAGR, in infant formula fortification.
• Spain: USD 19.05 million in 2025 with 12% share, projected USD 58.69 million by 2034 at 13.3% CAGR, with dietary supplement growth.

Asia-Pacific

Asia-Pacific leads production with 42% of global output, equivalent to more than 20,000 metric tons annually. China and India supply over 60% of global fermentation-based production, with exports to Europe and North America exceeding 10,000 metric tons annually. Consumption in Asia-Pacific reached 18,000 metric tons in 2023, with infant formula dominating demand at 55% of regional share.

The Asia market is valued at USD 222.21 million in 2025, holding 35% share, and projected to reach USD 684.67 million by 2034 at a CAGR of 13.4%.

Asia - Major Dominant Countries in the Algal DHA and ARA Market

• China: USD 88.88 million in 2025 with 40% share, projected USD 275.26 million by 2034 at 13.4% CAGR, dominating infant formula and supplements.
• India: USD 55.55 million in 2025 with 25% share, projected USD 171.16 million by 2034 at 13.5% CAGR, with nutraceutical manufacturing.
• Japan: USD 44.44 million in 2025 with 20% share, projected USD 137.00 million by 2034 at 13.3% CAGR, focused on dietary supplements.
• South Korea: USD 22.22 million in 2025 with 10% share, projected USD 68.50 million by 2034 at 13.4% CAGR, tied to fortified beverages.
• Indonesia: USD 11.11 million in 2025 with 5% share, projected USD 34.25 million by 2034 at 13.5% CAGR, led by infant food fortification.

Middle East & Africa

Middle East & Africa account for 8% of demand, consuming around 4,000 metric tons annually. Infant formula use drives 60% of consumption, especially in Gulf countries. Imports increased by 20% between 2021–2023, reflecting growing infant nutrition demand. South Africa, Saudi Arabia, and the UAE together account for 70% of MEA demand.

The Middle East and Africa market is valued at USD 63.50 million in 2025 with 10% share, projected to reach USD 195.62 million by 2034 at a CAGR of 13.3%.

Middle East and Africa - Major Dominant Countries in the Algal DHA and ARA Market

• Saudi Arabia: USD 19.05 million in 2025 with 30% share, projected USD 58.69 million by 2034 at 13.4% CAGR, driven by infant nutrition demand.
• UAE: USD 12.70 million in 2025 with 20% share, projected USD 39.13 million by 2034 at 13.3% CAGR, focused on fortified food imports.
• South Africa: USD 9.52 million in 2025 with 15% share, projected USD 29.34 million by 2034 at 13.3% CAGR, linked to supplements.
• Egypt: USD 7.62 million in 2025 with 12% share, projected USD 23.53 million by 2034 at 13.4% CAGR, in fortified dairy and food products.
• Nigeria: USD 6.35 million in 2025 with 10% share, projected USD 19.56 million by 2034 at 13.3% CAGR, supported by healthcare and food fortification.

List of Top Algal DHA and ARA Companies

• Shandong Yuexiang
• FEMICO
• Fuxing
• ADM
• Cellana
• Lonza Group
• AlgiSys
• Huison
• Yuexiang
• Runke
• Qingdao Keyuan
• CABIO
• JC Biotech
• Kingdomway
• Yidie
• DSM
• Roquette
• Corbion

Top Two Companies With Highest Share

• DSM and ADM together control more than 30% of the global algal DHA and ARA market, with combined annual production capacity exceeding 20,000 metric tons across multiple regions.

Investment Analysis and Opportunities

Investments in algal DHA and ARA production are focused on scaling fermentation capacity, developing powder formulations, and achieving vegan certification. Global production capacity exceeded 45,000 metric tons in 2024, with Asia-Pacific contributing 60%. Investments in spray-drying and encapsulation have expanded powder production to 15,000 metric tons annually, opening new B2B opportunities in beverages and nutraceuticals. Organic and vegan-certified product launches grew by 20–25% in recent years, commanding 15–20% price premiums in developed markets. Investors targeting essential infant formula demand can secure long-term contracts, as more than 75% of global formula brands are fortified with algal DHA and ARA.

New Product Development

New product innovations include encapsulated algal DHA powders, high-stability oils, and vegan-certified formulations. Encapsulation efficiency rates of 70–90% extend shelf life and improve dosage accuracy. In 2023, over 1,200 new products were launched globally featuring algal DHA and ARA, including functional beverages, infant cereals, and nutraceutical powders. Algal DHA-based supplements now represent 25% of vegan omega-3 launches worldwide. Advanced fermentation technologies achieved yields of 20 grams DHA per liter, reducing cost variability. Cosmetic products using algal ARA and DHA grew by 15% in the past three years, particularly in skincare and anti-aging formulations.

Five Recent Developments

• DSM expanded algal DHA capacity by 5,000 metric tons in 2023 through facility upgrades in Europe.
• ADM launched a vegan-certified DHA powder line in 2022, capturing over 10% share in powder formulations.
• Corbion increased production efficiency by 15% in 2023 using advanced fermentation technology.
• CABIO in China added 3,000 metric tons of capacity in 2023, strengthening Asia-Pacific’s dominance.
• Lonza introduced a new encapsulated algal ARA powder in 2022 with enhanced stability for infant nutrition.

Report Coverage of Algal DHA and ARA Market

This Algal DHA and ARA Market Report covers global production, consumption, segmentation, and trade analysis. It details production capacity of over 45,000 metric tons in 2024, with Asia-Pacific holding 42% of share, North America 30%, Europe 20%, and Middle East & Africa 8%. The report provides segmentation by type (DHA oil, DHA powder, ARA oil, ARA powder) and by application (infant formula 40%, food and beverages 25%, supplements 30%, others 5%). More than 75% of infant formula brands globally include algal DHA and ARA, representing 20,000 metric tons of annual usage. Supplements contribute 15,000 metric tons, while food and beverage applications use 12,000 metric tons annually. Company profiling includes DSM and ADM, which together control more than 30% of the market. The report also highlights key trends such as 20–25% growth in vegan-certified products, 18% increase in powder formulations, and 15% rise in cosmetic applications, supporting strategic decisions for manufacturers, suppliers, and investors.

Algal DHA and ARA Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 719.44 Million in 2026
Market Size Value By	USD 2200 Million by 2035
Growth Rate	CAGR of 13.32% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : DHA Oil DHA Powder ARA Oil ARA Powder By Application : Infant Formula Food and Beverage Nutritional Supplement Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample